The Wisconsin Department of Health Services has denied the sale of three nonprofit SSM Health nursing facilities to a New Jersey-based for-profit company, the Wisconsin State Journal reported Sept. 27 ...

Biopharmaceutical company Cassava Sciences, along with founder Remi Barbier and former Senior Vice President of Neuroscience Lindsay Burns, PhD, will pay more than $40 million to settle allegations ...

Norfolk, Va.-based Sentara Health is cutting about 200 positions, with a majority of the cuts coming from its health plan division.

CEO Dr. Jawad Shah has grown Insight Health System from a small physician office into a multistate hospital system.

The FDA has approved Cobenfy capsules from Bristol-Myers Squibb for the oral treatment of schizophrenia in adults. The medication, formerly known as KarXT, is the first antipsychotic medication to ...

Monique Díaz, MD, will assume the role of vice president and regional chief medical information officer for CommonSpirit Health's California region, according to her LinkedIn.

Boston-based Dana-Farber Cancer Institute will lead 12 other health systems and academic institutions across the U.S. in a new cancer consortium aimed at addressing health equity and survival rates ...

In the wake of 2023 walkouts by pharmacy workers dubbed "pharmageddon," major chains such as Walgreens and CVS are facing increased pressure from their employees to provide better working conditions ...

President Biden and Vice President Kamala Harris were joined by survivors of gun violence, local and state officials and advocates at the White House for the signing ceremony. Among them was Chethan ...

Learn about the recent ransomware attack on a Texas health system and how it is impacting patient care. Stay informed with these six key details.

A Challenger, Gray & Christmas report published Sept. 26 showed that 12 hospital CEOs left their roles in August, down from 16 reported in the same month last year. Those exits spanned the U.S., ...

The phase 3 Tempo-1 trial for tavapadon, a dopamine receptor partial agonist, demonstrated significant efficacy as a monotherapy in early Parkinson's disease. Patients receiving the drug at doses of 5 ...